| |
|
|
|
Kazia Therapeutics Limited  
|
|
3.07 0.26 (0.09%) |
05-29 16:00 |
|
Open: |
2.88 |
Pre close: |
2.81 |
Target:
|
3.89 
|
|
High: |
3.2299 |
Low: |
2.78 |
Resistance:
|
3.33
3.89
|
|
Volume: |
93,935 |
Market Cap: |
22M |
Support:
|
2.82
2.50
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.81
|
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
2.71 |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
3.47  |
Stochastic Oscillator |
%K(14,3):
|
43.78 |
|
MA(250): |
3.33 |
%D(3): |
33.87 |
|
Average Volume(K) |
3-Month: |
3520
|
52-Week |
High:
|
9.74 |
|
10-Days: |
3020 |
Low: |
2.24 |
|
RSI |
RSI(14):
|
61.66 |
Change(%): |
5.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.920 |
Return on Equity (ttm) |
-66.1 |
Shares Out. (M) |
7.22 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-25.9 |
Shares Float (M) |
4.02 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-18.6 |
% Held by Institutions |
3.56 |
|
Forward EPS |
-1.258 |
Gross Profit (p.s.) |
0.213 |
Shares Short (K) |
1 |
|
Book Value (p.s.) |
2.940 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.34 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.04 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
